Marrone Bio Innovations (MBII) Receives Daily Media Sentiment Rating of 0.16

Media coverage about Marrone Bio Innovations (NASDAQ:MBII) has been trending somewhat positive on Tuesday, Accern Sentiment reports. Accern scores the sentiment of press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Marrone Bio Innovations earned a media sentiment score of 0.16 on Accern’s scale. Accern also gave media stories about the basic materials company an impact score of 44.4891800718433 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Separately, HC Wainwright set a $4.00 target price on Marrone Bio Innovations and gave the stock a “buy” rating in a research report on Thursday, December 21st. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the stock. Marrone Bio Innovations currently has an average rating of “Hold” and a consensus target price of $2.50.

Marrone Bio Innovations (NASDAQ:MBII) traded up $0.13 during midday trading on Tuesday, reaching $1.32. The company had a trading volume of 293,500 shares, compared to its average volume of 155,680. Marrone Bio Innovations has a 1 year low of $0.85 and a 1 year high of $2.45. The stock has a market capitalization of $41.28, a P/E ratio of -1.15 and a beta of 0.31. The company has a debt-to-equity ratio of -1.14, a current ratio of 0.69 and a quick ratio of 0.36.

WARNING: This report was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this report on another website, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The correct version of this report can be accessed at

Marrone Bio Innovations Company Profile

Marrone Bio Innovations, Inc offers bio-based pest management and plant health products. The Company’s bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene.

Insider Buying and Selling by Quarter for Marrone Bio Innovations (NASDAQ:MBII)

Receive News & Ratings for Marrone Bio Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marrone Bio Innovations and related companies with's FREE daily email newsletter.

Leave a Reply